Research & Clinical Trials

Research and advances in technology are constantly changing the face of vision correction techniques. Dr. Ernest is known for his contributions to the field of ophthalmology and actively participates in new developments of tools, treatments and procedures to offer his patients the best possible care. Industry manufacturers often seek his opinion and request Dr. Ernest to trial new equipment and treatments in an effort to improve on current technology. Dr. Ernest is dedicated to finding new options to improve his patient’s quality of life. Some of Dr. Ernest’s contributions include:

• Pioneer of the no-stitch cataract surgery method that is widely used today.

• Development of the Ernest Nucleus Cracker tool used during cataract surgery.

• Reducing the amount of surgically induced astigmatism during cataract surgery with precise small incisions.

The development of new treatments and cures would not be possible without healthcare research. Thanks to the advances in ophthalmology many diseases of the eye that previously resulted in blindness can now be treated and/or cured improving a patients quality of life.

To ensure that health research is safe, studies are designed to keep the risks to subjects as low as possible. There are also protections and safeguards that are required by law. To ensure that a study is conducted safely, a review board called the Institutional Review Board (IRB) must review and approve each protocol. The IRB is made up of a team of doctors, nurses, researchers, and members of the community. The IRB also makes sure that there is little risk for participants. All studies have a very detailed "protocol," or study plan.

Study participants must meet very specific criteria based on each studies requirements. To learn more about specific studies and study criteria visit ClinicalTrials.gov for a complete list.

There are many benefits to participating in clinical studies. Study participants receive advanced technology before the general public and may help benefit many other patients in the future.

  • Principal Investigator
    C-08-062 Acrosof TORIC T9 IOL
    February 2009-Present
    Alcon Labratories
  • Principal Investigator
    C-06-40 ACRYSOF ReSTOR
    Aspheric +3.0D add power IOL
    August 2007-April 2008
    Alcon Laboratories
  • Principal Investigator
    ReSTOR 4.0 Aspheric A-Constant Study
    March – April 2007
    Alcon Laboratories
  • Principal Investigator
    Protocol CMS-06-05
    Nevanac, Zybrom & Acular
    2006
  • Principal Investigator
    Intermediate vision with
    Multifocal IOL’s (ReSTOR)
    2006
  • Principal Investigator
    ReSTOR / Hyperopic Monovision
    2006
  • Principal Investigator
    C-04-31 Double-Masked, Paralled Design,
    Randomized, Single Dose, Bioequivalence
    Study of Tobradex BAC-Free and
    Tobradex Ophthalmic Formulations.
    2005-2006
  • Principal Investigator
    Toric IOL Clinical Study
    2001-2003
  • Principal Investigator
    Advanced Phacoemulsification technology
    Neosonics 2001
  • Principal Investigator
    Medenium Phakic refractive lens
    2001
  • Principal Investigator
    Alcon Blue Blocker IOL Study
    2001
  • Principal Investigator
    The Monarch I & Monarch II Injectors for
    Acrylic IOL insertion
    2000
  • Principal Investigator
    Single Piece AcrySof Acrylic Lens
    1999
  • Principal Investigator
    Laser Thermal Keratoplasty
    1998
  • Principal Investigator
    Piggy Back IOL Study with evaluation of
    contrast sensitivity, depth of focus
    1997
  • Principal Investigator
    Array Multifocal IOL Study
    1996
  • Principal Investigator
    Alcon comparison of Viscoelastic VS. Healon Study
    1995-1996
  • Principal Investigator
    PCO study comparing rates of PCO & YAG capsulotomies
    between Alcon MA60 & Allergan SI40 IOL
    1995-1999
  • Principal Investigator
    Alcon AcrySof foldable IOL study
    1994
  • Principal Investigator
    ORC Memory Lens Study
    1990
  • Principal Investigator
    Allergan SI18 Silicone Foldable Lens
    1987-1988
  • Principal Investigator
    Epikeratophakia Study
    1984

Make an Appointment

Contact